<DOC>
	<DOCNO>NCT00275496</DOCNO>
	<brief_summary>Subjects must diagnose melanoma . All subject receive Wide Excision ( WEX ) melanoma . If melanoma meet study requirement , subject randomize receive either ( 1 ) surgical procedure part study ( 2 ) Selective Lymphadenectomy possibility Complete Lymphadenectomy . Subjects follow 10 year .</brief_summary>
	<brief_title>Multicenter Selective Lymphadenectomy Trial ( MSLT )</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>1 . The patient consent study . 2 . The patient must invasive melanoma : 1 ) Clark Level III Breslow Thickness great equal 1.00 mm ; 2 ) Clark Level IV V Breslow thickness . A confirmation diagnosis thickness must make institutional pathologist . 3 . The primary cutaneous melanoma site must head , neck , trunk , extremity , scalp , palm hand , sole foot , subungual skin . 4 . The patient 's biopsy must complete 10 week initial visit clinic . ( Surgery must schedule within three month biopsy . ) 5 . The patient must 18 75 year old . 6 . The patient must life expectancy least 10 year time diagnosis , exclude diagnosis melanoma . 1 . The patient prior wide excision primary diameter excision great equal 3.0 cm short margin tumor edge excision edge measure pathologist great equal 1.5 cm ; patient elliptical excision margin beyond tumor edge great equal 1.5 cm narrow margin . 2 . The primary cutaneous melanoma involve eye , ear , mucous membrane . 3 . The patient clinical evidence satellite lesion , intransit , regional nodal distant metastasis . 4 . The patient second primary invasive melanoma . 5 . The patient type solid tumor hematologic malignancy past 5 year . Exceptions patient treat T1 lesion ( e.g. , squamous cell carcinoma skin , basal cell carcinoma situ carcinoma uterine cervix ) past 5 year , receive treatment within last 6 month . 6 . The patient prior skin graft , tissue transfer flap , lymph node dissection may alter lymphatic drainage pattern primary cutaneous melanoma adjacent regional lymph node basin . 7 . The patient previous chemotherapy , immunotherapy radiation therapy . 8 . The patient organ transplantation receive immunosuppressive agent result transplantation . 9 . The patient take oral parenteral steroid immunosuppressive drug within last 6 month . 10 . The patient know primary secondary immune deficiency . 11 . The patient another medical condition affect life expectancy . 12 . The patient pregnant . 13 . Evidence patient undergo selective lymph node dissection reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>SLND</keyword>
	<keyword>Sentinel</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Surgical</keyword>
</DOC>